The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksShire Share News (SHP)

  • There is currently no data for SHP

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET MIDDAY: Stocks Higher As Shire And Whitbread Gain

Fri, 14th Sep 2018 12:01

LONDON (Alliance News) - Stocks in London were higher at midday on Friday with Shire and Whitbread performing well among FTSE 100 constituents, while in the FTSE 250, Investec was benefiting from its plan to demerge its asset management businesses. The FTSE 100 index was 0.4%, or 27.10 points, at 7,308.72 at midday. The FTSE 250 was up 0.5%, or 97.90 points to 20,341.44, while the AIM All-Share index was flat at 1,097.10.The Cboe UK 100 index was up 0.3%, or 40.75 points, at 12,372.97. The Cboe UK 250 was up 0.5%, or 94.09 points to 18,487.59, and the Cboe UK Small Companies was down 0.1% at 12,190.36."European stocks are slightly higher this morning as traders are cautiously optimistic about the state of global trade. The US and China are still locked in a trade spat, and both sides are content to hold their positions. Traders are viewing no new negative news as a positive for stocks," said CMC Markets analyst David Madden. On the London Stock Exchange, Shire was the best performer in the FTSE 100, up 2.4% at 4,502.50 pence after Takeda Pharmaceutical said it had received regulatory clearance in China for its GBP46 billion acquisition of the Irish drugmaker. The Japanese firm received unconditional approval for the deal announced in May from the State Administration for Market Regulation in China in what it termed "another key step" in the transaction process. Chinese approval follows progress with other global regulators. In July, the deal received the green light from the US Federal Trade Commission. It also has received unconditional approval from the Brazilian Administrative Council for Economic Defense. Under the deal, Takeda will pay USD30.33 in cash and 0.839 of a new Takeda share for each Shire share. This values the deal at around 4,990 pence per Shire share based on current prices and exchange rates.Another blue-chip winner was Whitbread, which was up 1.5%. The Costa Coffee shop and Premier Inn hotel chain owner was raised to Overweight from Neutral. Last month, Whitbread agreed to sell Costa to Coca-Cola for GBP3.8 billion and return the vast majority of that to shareholders.In the FTSE 250, Investec was the best performer, up 8.4%. The Anglo-South African financial services firm said its interim profit is expected to be ahead of last year, as it also announced plans to demerge and publicly list its Asset Management unit. Following the conclusion of a strategic review, the company said that there are "compelling" linkages between its Specialist Banking and Wealth & Investment business. However, there are "limited synergies" between both of these divisions and Investec Asset Management. Therefore, the board has decided to demerge and publicly list the asset management unit. Separately, Investec said although its first half saw "macro challenges" in both South Africa and the UK, operating profit for the period is expected to be above last year.At the other end of the FTSE 250, JD Wetherspoon was down 0.9%. The pub chain said taxes, labour, and interest costs are expected to be higher year-on-year, despite reporting growth in profit. For the 52 weeks to July 29, Wetherspoons recorded pretax profit of GBP107.2 million, up 4.3% year-on-year, with pretax profit rising 6.2% excluding an extra week in its prior financial year.Revenue was GBP1.69 billion compared to GBP1.66 billion a year before. Like-for-like sales, adjusted for 52 weeks, increased by 5.0% versus 4.0% the year prior. Looking ahead, the company estimates it will be required to achieve like-for-like sales growth of about 4.0% in its new financial year to match Friday's profit figure. Same store sales in the six weeks to September 9 were up 5.5%, a "reasonable" start to the year.Wetherspoon's opened six pubs during its year, with 18 sold or closed, resulting in a trading estate of 883 pubs at end of its 2018 financial year.The pound was quoted at USD1.3125 compared to USD1.3101 at the London equities close on Thursday. Bank of England Governor Mark Carney warned UK ministers that house prices could crash by more than a third in the event of a chaotic no-deal Brexit. Carney briefed Prime Minister Theresa May and senior ministers on the bank's planning for a "cliff-edge" break with the EU at a special Cabinet meeting on Thursday to review the government's no-deal preparations. It is understood he warned house prices could fall by up to 35% over three years in a worst-case scenario, as sterling plummeted and the Bank was forced to push up interest rates. According to reports, he compared the fall-out from such a disorderly departure to the 2008 global financial crash. Ministers were said to have listened in silence as he and Chancellor Philip Hammond spelled out the grim consequences for the economy. His bleak prognosis came as France said it could halt flights and Eurostar trains from the UK if there was no agreement when the UK leaves the EU in March 2019."Mark Carney is risking the ire of hard Brexiteers once more this morning as the governor for the Bank of England has warned that a no-deal Brexit could lead to economic chaos which would see house price crash by as much as a third," said XTB analyst David Cheetham. "On the flip side, Carney also noted that PM May's much maligned Chequers exit plan, should it manage to be agreed upon, would see the economy perform better than the bank's assumed outcome," Cheetham added. On Thursday, Bank of England policymakers unanimously decided to maintain their monetary policy stance unchanged after a quarter-point rate hike in August. The Monetary Policy Committee voted 9-0 to keep the key rate unchanged at 0.75%.In Paris the CAC 40 was up 0.4%, while the DAX 30 in Frankfurt was up 0.3%. The euro was quoted at USD1.1697 at midday, marginally higher against USD1.1673 European equities close Thursday. US stocks are pointed towards a slightly higher start on Friday. The Dow Jones called up 0.1%, S&P 500 flat and Nasdaq Composite up 0.2%."The US economy has been gathering positive momentum despite the risk of a trade war and today's retail sales data is expected to provide further evidence of that, with spending expected to have risen by 0.4% last month. This would continue the steady trend of rising sales over the course of the year as consumers spend the additional income that tax cuts afforded them thanks to last year's reforms," said Oanda analyst Craig Erlam.Still to come in the economics events calendar are US retail sales and import and export prices at 1330 BST.
More News
14 Sep 2018 09:15

Shire gains as takeover approved by China

(Sharecast News) - Japan's Takeda Pharmaceutical has received regulatory approval from China for its $62bn takeover of London-listed Shire.

Read more
13 Sep 2018 10:56

Takada eyeing potential Shire asset sales to pay down debt

(Sharecast News) - Takeda Pharmaceutical may try and sell Shire's dry-eye drug once it completes the $62bn takeover purchase of the UK-listed biotech, according to a report on Thursday.

Read more
13 Sep 2018 08:25

Takeda weighs sale of Shire's eye care business to cut debt- Bloomberg

Sept 13 (Reuters) - Japan's Takeda Pharmaceutical is considering selling Shire Plc's eye care business once it closes its $62 billion purchase of the London-listed drugmaker, as it looks a

Read more
12 Sep 2018 16:12

Takeda to pack up Illinois HQ, nearly 1,000 workers to be affected

Sept 12 (Reuters) - Japan's Takeda Pharmaceutical Co Ltd said on Wednesday it plans to shut its U.S. headquarters in Deerfield, Illinois and move it to the greater Boston area, following the —

Read more
12 Sep 2018 07:22

Shire gets EC marketing authorisation for 'VEYVONDI' treatment

(Sharecast News) - Rare diseases specialist Shire announced on Wednesday that the European Commission has granted marketing authorisation for 'VEYVONDI', for the treatment of bleeding events and the treatment and prevention of surgical bleeding in adults with von Willebrand disease, when desmopressin treatment alone is ineffective or not indicated.

Read more
10 Sep 2018 16:08

Two Shire Subsidiaries Receive Majority Early Offers For Senior Notes

LONDON (Alliance News) - Biotechnology company Shire PLC on Monday said two of its subsidiaries, Baxalta Inc and Shire Acquisitions Investments Ireland DAC, had received early offers for a of the

Read more
7 Sep 2018 09:33

BROKER RATINGS SUMMARY: Goldman Cuts Burberry; Redburn Cuts HSBC

LONDON (Alliance News) - The following London-listed shares received analyst recommendations Friday morning and Thursday:----------FTSE 100----------GOLDMAN CUTS GROUP TO BUY -

Read more
6 Sep 2018 11:20

European Shares Reverse Early Losses On Improving Sentiment

BRUSSELS/FRANKFURT/PARIS (Alliance News) - European stocks were marginally higher on Thursday after having fallen to a five-month low earlier in the day.Sentiment improved somewhat after US

Read more
6 Sep 2018 10:54

TOP NEWS: Shire Buys Swiss Plasma Collection Firm Sanaplasma

LONDON (Alliance News) - Shire PLC said Thursday it has bought Swiss source plasma collection company sanaplasma AG for an undisclosed sum.The FTSE 100 pharmaceutical giant said that the is

Read more
6 Sep 2018 10:52

Shire buys Swiss plasma firm sanaplasma for undisclosed sum

(Sharecast News) - Pharmaceuticals giant Shire on Thursday said it had bought Switzerland's sanaplasma AG for an undisclosed sum.

Read more
6 Sep 2018 07:48

UPDATE 1-UK Stocks-Factors to watch on Sept. 6

Sept 6 (Reuters) - Britain's FTSE 100 futures were down 0.1 percent ahead of the cash market open on Thursday. * DIXONS CARPHONE: Dixons Carphone, the troubled British electricals and a

Read more
31 Aug 2018 10:16

Shire Completes USD2.4 Billion Oncology Franchise Sale To Servier

LONDON (Alliance News) - Irish biotechnology giant Shire PLC said Friday it has completed the sale of its oncology franchise to Servier SAS.The FTSE 100-listed company sold its franchise, a

Read more
31 Aug 2018 09:07

Shire completes $2.4bn oncology sale to Servier

(Sharecast News) - Shire has completed the sale of its oncology franchise to Servier for $2.4bn, it announced on Friday.

Read more
24 Aug 2018 14:04

TOP NEWS: Shire Launches Tender Offer To Buy Up To USD2 Billion Notes (ALLISS)

LONDON (Alliance News) - Biotechnology company Shire PLC on Friday said its wholly-owned subsidiaries Baxalta and Shire Acquisitions Investments Ireland DAC launched a tender offer to repurchase a

Read more
24 Aug 2018 13:54

MARKET ANALYSIS: Futures Pointing To Initial Strength On Wall Street

WASHINGTON (Alliance News) - The major US index futures are pointing to a higher opening on Friday, with stocks likely to move to the upside after ending the previous session modestly upward on a

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.